
74
_5RPkQă
Avertisment!
UPăWRDUHOH FXYLQWH VLPERO úL vQĠHOHVXO ORU DX LQWHQĠLD GH D
explica nivelele de risc asociate cu acest produs.
PERICOL
,QGLFă R VLWXDĠLH SHULFXORDVă LPLQHQWă FDUH GDFă QX
HVWHHYLWDWăYDFDX]DGHFHVXOVDXYăWăPDUHDJUDYă
AVERTISMENT
,QGLFă R VLWXDĠLH SHULFXORDVă LPLQHQWă FDUH GDFă QX
HVWHHYLWDWăSRDWHUH]XOWDvQGHFHVVDXYăWăPDUHJUDYă
$7(1ğ,(
,QGLFă R VLWXDĠLH SRWHQĠLDO SHULFXORDVă FDUH GDFă QX
HVWH HYLWDWă SRDWH FDX]D YăWăPDUHD PRGHUDWă VDX
XúRDUă
$7(1ğ,(
)ăUăDVLPEROXOGHDOHUWăSULYLQGVLJXUDQĠD
,QGLFăRVLWXDĠLHFDUHSRDWHGXFHODSDJXEHPDWHULDOH
Summary of Contents for RBV3000CESV
Page 53: ...EN FR DE ES IT NL PT DA SV FI NO RU PL CS HU RO LV LT ET HR SL SK BG 51 _ 5 51 99...
Page 54: ...52 _...
Page 55: ...EN FR DE ES IT NL PT DA SV FI NO RU PL CS HU RO LV LT ET HR SL SK BG 53 _...
Page 56: ...54 _ 5D QDXG V 6 QGURPH Raynaud s Syndrome 1 2 3 4 5 6 7 8 9 10 11 12 13...
Page 57: ...EN FR DE ES IT NL PT DA SV FI NO RU PL CS HU RO LV LT ET HR SL SK BG 55 _ 14 267 5 108...
Page 101: ...EN FR DE ES IT NL PT DA SV FI NO RU PL CS HU RO LV LT ET HR SL SK BG 99 _ 2 P 51 99 2II...
Page 102: ...100 _ 3...
Page 103: ...EN FR DE ES IT NL PT DA SV FI NO RU PL CS HU RO LV LT ET HR SL SK BG 101 _...
Page 104: ...102 _ 5D QDXG V 6 QGURPH 5D QDXG V 6 QGURPH 1 2 3 4 5 6 7 8 9 10 11 12 13 14...
Page 106: ...104 x 1 x 1 x 1 x 1 x 1 x 1 x 1 x 1 x 1 x 1...
Page 107: ...105 11 12 6 5 4 7 8 9 10 1 2 3 13 14...
Page 108: ...106 1 8 2...
Page 109: ...107 1 3 4 5 2 1 2 1 2 1 2 3 4 1 2 3 5 7 9 10 4 6...
Page 110: ...108...
Page 111: ...109 p 110 p 110 p 111 p 113 p 115 p 116 p 117...
Page 112: ...110 2 2 1 1...
Page 113: ...111 1 1 2 2 3 4...
Page 114: ...112 6 5 7 8...
Page 115: ...113 1 1 2 1 3 2 2 3 4...
Page 116: ...114 1 2 5 1 2 6 7 8...
Page 117: ...115 1 3 2 1 2 3...
Page 118: ...116 1 2...
Page 119: ...117 4 3 2 1 2 1 6 2 1 3 4 5 2 4 1 3 20140710v1...
Page 142: ......
Page 143: ......
Page 144: ......